During the past decade, MD Anderson Regional Care Center-Bay Area conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson Regional Care Center-Bay Area" #1 sponsor was "SWOG Cancer Research Network" with 7 trials, followed by "M.D. Anderson Cancer Center" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Regional Care Center-Bay Area" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson Regional Care Center-Bay Area" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (3 trials), "Fallopian Tube Serous Adenocarcinoma" (3 trials) and "Ovarian Clear Cell Adenocarcinoma" (3 trials). Many other conditions were trialed in "MD Anderson Regional Care Center-Bay Area" in a lesser frequency.

Most popular intervention types in "MD Anderson Regional Care Center-Bay Area" are "Drug" (15 trials), "Other" (14 trials), "Biological" (5 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (4 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson Regional Care Center-Bay Area" are 10 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson Regional Care Center-Bay Area". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in MD Anderson Regional Care Center-Bay Area, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson Regional Care Center-Bay Area, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".